Micronutrients for Attention-Deficit/Hyperactivity Disorder in Youths: A Placebo-Controlled Randomized Clinical Trial
Twenty-year effects of antipsychotics in schizophrenia and affective psychotic disorders
Studies that examine course and outcome in psychosis have reported considerable heterogeneity in terms of recovery, remission, employment, symptom presentation, social outcomes, and antipsychotic medication effects. Even with demonstrated heterogeneity in course and outcome, prophylactic antipsychotic maintenance therapy remains the prominent practice, particularly in participants with schizophrenia. Lack of efficacy in maintenance antipsychotic treatment and concerns over health detriments gives cause to re-examine guidelines.
The diverse functions of hearing voices peer-support groups: findings and case examples from a US national study
Hearing voices peer-support groups enable people coping with voices, visions, or other unshared perceptual experiences to explore the particularities and potential meanings of their experiences while receiving support from others facing similar challenges. They have now spread to 30 countries on five continents, and many members report profound life changes as a result of participating.
A Holistic Self-learning Approach for Young Adult Depression and Anxiety Compared to Medication-Based Treatment-As-Usual
Development of a composite primary outcome score for children with ADHD and emotional dysregulation
Rationale and design of an international randomized placebo-controlled trial of a 36-ingredient micronutrient supplement for children with ADHD and irritable mood: The Micronutrients for ADHD in Youth (MADDY) study
Attention-Deficit/Hyperactivity Disorder (ADHD) is a chronic neurodevelopmental disorder
affecting up to 9% of children and substantial numbers of adults. Existing pharmacologic treatments often
improve symptoms, but concerns exist over side effects, stigma, potential long-term health effects, and residual
irritability, often treated with adjunctive antipsychotics. To address public and clinician demand for nonpharmacologic evidence-based treatments, this study will examine efficacy of a 36-ingredient micronutrient
(vitamin/mineral) supplement as treatment for children with ADHD and irritability.